BlackRock TCP Capital (TCPC) Q4 2025 earnings review
NAV Collapses 19% Amid Massive Write-downs; Dividend Slashed
TCPC suffered a devastating quarter, with Net Asset Value (NAV) plummeting 19% sequentially to $7.07 per share. The aggressive NAV erosion was driven by severe issuer-specific markdowns, with six portfolio companies accounting for 67% of the decline. Highlighting the fundamental deterioration in earnings power, Adjusted Net Investment Income decelerated to $0.25 per share, forcing the Board to slash the Q1 2026 regular dividend by 32% to $0.17. Compounding the distress, net regulatory leverage accelerated to an uncomfortable 1.41x, well outside management's target range.
🐂 Bull Case
Management noted that approximately 91% of the NAV reduction was tied to investments underwritten in 2021 or earlier. If these pandemic-era, low-base-rate mistakes are fully written down, the core portfolio may be nearing a bottom.
TCPC continues to execute a strategic pivot to senior-secured, first-lien loans (now 87.4% of portfolio), leveraging the vast origination resources of the newly integrated BlackRock PFS (HPS) platform to source safer credits.
🐻 Bear Case
Net realized and unrealized losses topped $140M in Q4 alone. Repeated restructuring failures on legacy names have permanently destroyed significant shareholder value, reflected in the $1.39 per share drop in net assets from operations.
With net regulatory leverage spiking to 1.41x (up from 1.14x a year ago), TCPC has breached its 0.9x-1.2x target. This limits their ability to originate new, healthier loans and may force sub-optimal asset liquidations.
⚖️ Verdict: 🔴🔴
Bearish. A 19% sequential drop in NAV, a massive 32% dividend cut, and leverage spiking far above target limits present a highly distressed picture. Management's turnaround efforts are being overwhelmed by the collapse of legacy 2021-vintage assets.
Key Themes
Catastrophic Mark-to-Market Revaluations
The scale of Q4 credit markdowns was staggering. Net realized losses were $73.9M (driven by Anacomp, Astra, HomeRenew), and net unrealized losses were $66.5M (driven by Edmentum, Infinite/Razor, SellerX). This reverses the stabilization narrative management attempted to build in Q3. The fact that six companies drove two-thirds of the NAV drop indicates high concentration risk within the stressed bucket.
Non-Accruals Reverse Prior Improvements
After three quarters of steady improvement, non-accruals reversed direction, climbing to 4.0% of the portfolio at fair value and 9.7% at cost (up from 3.5% and 7.0% in Q3). This persistent credit stress demonstrates that earlier restructurings have failed to insulate the portfolio from sustained higher interest rates.
Dangerous Leverage Spike
Net regulatory leverage accelerated drastically to 1.41x, up from 1.20x in Q3 and well above the company's stated historical target of 0.9x to 1.2x. This mechanically occurred due to the shrinking equity base (NAV collapse) rather than aggressive borrowing, but the result is a constrained balance sheet right when flexibility is needed to fund the portfolio rotation.
Yield Compression Squeezing Income
The weighted average effective yield of the debt portfolio decelerated to 11.1%, down from 11.5% in Q3 and 12.4% a year ago. New Q4 investments yielded just 9.7%, while exited investments yielded 11.1%. This negative spread on rotation ensures core earning power will remain suppressed, perfectly explaining the necessity of the dividend cut.
Other KPIs
Reversing off a cliff. NAV dropped 19% sequentially from $8.71 in Q3. Cumulative NAV decline over the trailing 12 months is 23% (down from $9.23 in 24Q4).
Decelerating. Down from $25.6 million ($0.30 per share) in 25Q3 and $30.8 million ($0.36 per share) in 24Q4. The drop is a direct result of yield compression, smaller overall portfolio size due to write-downs, and elevated non-accruals.
TCPC repurchased over 500k shares in 2025 at an average price of $5.84, and an additional 233,541 shares post-Q4 at $5.50. While highly accretive to the newly depressed $7.07 NAV, these volumes reflect a market trading the stock at distressed discount levels.
Guidance
Decelerating violently. This is a 32% cut from the $0.25 regular dividend paid in Q4 2025, and a 50% cut from the $0.34 regular dividend paid in Q4 2024. The massive reduction resets the payout to align with a structurally impaired portfolio yield and lower asset base.
Key Questions
Leverage Remediation Plan
With net regulatory leverage spiking to 1.41x, far above your 0.9x-1.2x target, what is the specific timeline and mechanism for de-leveraging? Will you be forced into sub-optimal asset sales in a tough secondary market to cure this?
Downside Protection on Restructurings
Six portfolio companies accounted for 67% of the NAV decline this quarter. Have these specific assets been marked down to liquidation value, or is there still meaningful remaining exposure that could drive further write-downs in 2026?
Dividend Re-basing
You cut the dividend to $0.17 per share. Does this new level assume further yield compression from rate cuts, or does it bake in a buffer for future non-accruals?